• AAPL 169.02
  • TSLA 162.13
  • AMZN 176.59
  • MSFT 409.06
  • INTC 34.5
  • EURUSD 1.0725
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. CDXC.NASDAQ

Chromadex Corp (CDXC NASDAQ) stock market data APIs

$3.47 0.07(2.1%) as of April 24, 2024

Chromadex Corp Financial Data Overview

3.4
3.47
-
3.65
3.37
1.25-4.65
257 M
75 309 K
83 570 K
0.0015
1.99
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CDXC',
Type: 'Common Stock',
Name: 'Chromadex Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: '1386570',
EmployerIdNumber: '26-2940963',
FiscalYearEnd: 'December',
IPODate: '2008-07-15',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Chromadex Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 83 570 K
  • EBITDA -4 571 000
  • Earnings Per Share -0.07
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Chromadex Corp Earnings via APIs

  • Latest Release 2024-03-06
  • EPS/Forecast -0.03

Get Chromadex Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Chromadex Corp latest news via APIs

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

LOS ANGELES, January 26, 2024--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, today announced that its Chi...

ChromaDex Corporation's (NASDAQ:CDXC) Shift From Loss To Profit

With the business potentially at an important milestone, we thought we'd take a closer look at ChromaDex Corporation's (NASDAQ:CDXC) future prospects. ChromaDex Corporation operates as a bioscience co...
Do you have any questions?
support@eodhistoricaldata.com